Summary
- Current Price
- As of today, ABCL price is $11.62, up +2.20% in the most recent trading session on
- Current Price All-Time High
- ABCL price is currently -83.84% below its historical high of $71.91 set on
- Market Cap
- ABCL current market cap is $4B, up +120.54% over the past 365 days
- Revenue
- ABCL current annual revenue is $75.13M, up +160.56% year-over-year
- Next Earnings
- The next earnings release for ABCL is on
Profile
| Metric | Value |
|---|---|
| Full Name | AbCellera Biologics Inc. |
| Ticker | NASDAQ: ABCL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | abcellera.com |
| Employees | 596 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $11.62 | |
| Price, 1D Change | +2.20% | |
| $4B | ||
| - | ||
| - | ||
| 2.55 | ||
| $75.13M | ||
| Revenue, 1Y Change | +160.56% | |
| -$0.49 | ||
| EPS, 1Y Change | +11.42% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.49 | ||
| EPS Estimate | -$0.67 | N/A |
| EPS Est. Change | -37.54% | N/A |
| $75.13M | ||
| Revenue Estimate | $26.37M | N/A |
| Revenue Est. Change | -64.90% | N/A |
| Current Price | $11.62 | |
| Price Target | $15.00 | - |
| Price Tgt. Change | +29.09% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.59 | -$0.55 | +6.68% | |
| -$0.63 | -$0.49 | +22.61% | |
| -$0.67 | N/A | -37.54% | |
| -$0.76 | N/A | -55.58% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $31.58M | $28.83M | -8.70% | |
| $36.29M | $75.13M | +107.01% | |
| $26.37M | N/A | -64.90% | |
| $28.24M | N/A | -62.41% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $11.62 | |
| $6.60 | ||
| $12.14 | ||
| $7.82 | ||
| $11.54 | ||
| -$0.06 | ||
| 2.55 | ||
| $0.80 | ||
| 41.79 | ||
| 65.05% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $75.13M | ||
| -$0.49 | ||
| $46.31M | ||
| 61.64% | ||
| -$217.10M | ||
| -288.98% | ||
| -$146.41M | ||
| -194.88% | ||
| -$188.28M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.15 | ||
| 11.32 | ||
| 11.23 | ||
| - | ||
| 4 | ||
| 10.56 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 56.90 | ||
| 4.20 | ||
| -17.32 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $966.90M | ||
| $560.33M | ||
| $1.36B | ||
| $728.23M | ||
| $215.59M | ||
| $64.31M | ||
| $143.22M | ||
| $5.82M | ||
| $25.23M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $221.54M | ||
| $263.41M | ||
| $28.82M | ||
| $0.00 | ||
| $28.82M | ||
| $0.00 | ||
| -$31.18M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$131.30M | ||
| $87.75M | ||
| $14.08M | ||
| $42.77M | ||
| -$174.07M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| UBS | ||
| JP Morgan | ||
| Truist Securities | → | |
| Stifel | → | |
| Cantor Fitzgerald | → | |
| Benchmark | → | |
| Cantor Fitzgerald | ||
| Jones Trading | ||
| Leerink Partners | → | |
| Stifel | → |
Analyst sentiment
Institutional ownership
Screeners with ABCL
FAQ
- What is the ticker symbol for AbCellera Biologics Inc.?
- The ticker symbol for AbCellera Biologics Inc. is NASDAQ:ABCL
- Does AbCellera Biologics Inc. pay dividends?
- No, AbCellera Biologics Inc. does not pay dividends
- What sector is AbCellera Biologics Inc. in?
- AbCellera Biologics Inc. is in the Healthcare sector
- What industry is AbCellera Biologics Inc. in?
- AbCellera Biologics Inc. is in the Biotechnology industry
- What country is AbCellera Biologics Inc. based in?
- AbCellera Biologics Inc. is headquartered in Canada
- When did AbCellera Biologics Inc. go public?
- AbCellera Biologics Inc. initial public offering (IPO) was on December 11, 2020
- Is AbCellera Biologics Inc. in the S&P 500?
- No, AbCellera Biologics Inc. is not included in the S&P 500 index
- Is AbCellera Biologics Inc. in the NASDAQ 100?
- No, AbCellera Biologics Inc. is not included in the NASDAQ 100 index
- Is AbCellera Biologics Inc. in the Dow Jones?
- No, AbCellera Biologics Inc. is not included in the Dow Jones index
- When was AbCellera Biologics Inc. last earnings report?
- AbCellera Biologics Inc.'s most recent earnings report was on August 5, 2026
- When does AbCellera Biologics Inc. report earnings?
- The next expected earnings date for AbCellera Biologics Inc. is November 9, 2026
Data Sources & References
- ABCL Official Website www.abcellera.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1703057/000170305726000012/0001703057-26-000012-index.htm
- ABCL Profile on Yahoo Finance finance.yahoo.com/quote/ABCL
- ABCL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abcl